Iranian journal of pharmaceutical research : IJPR

Iran J Pharm Res · ISSN (e) 1726-6890 · 8 papers in corpus
other 2024
doi:10.5812/ijpr-153636 ·PMID:40066111

BACKGROUND: The positive effects of growth hormone (GH) on the endometrium, including increased endometrial blood supply and enhanced expression of cytokines associated with endometrial receptivity, have been noted. However, data on the eff…

article 2024
doi:10.5812/ijpr-144266 ·PMID:39108650

BACKGROUND: Endometriosis is a chronic gynecological disorder characterized by the ectopic growth of endometrial tissue outside the uterus, leading to debilitating pain and infertility in affected women. Despite its prevalence and clinical …

2021
doi:10.22037/ijpr.2021.114891.15088 ·PMID:34400954

Personal care products (PCPs) are generally used for personal hygiene, cleaning, grooming, and beautification. These include hair and skin care products, baby care products, UV blocking creams, facial cleansers, insect repellents, perfumes,…

article 2019
doi:10.22037/ijpr.2019.1100642 ·PMID:31531066

< 0.05) in both EEE and NE groups. In conclusion, higher doses of noscapine showed inhibitory effect on growth and angiogenesis of EEE and NE.

2019
doi:10.22037/ijpr.2020.1100961 ·PMID:32802108

Primary dysmenorrhea is a common gynecological disorder in women of reproductive age. Despite the effective conventional treatments such as nonsteroidal anti-inflammatory drugs and oral contraceptives, researchers have always been looking f…

2018
·PMID:30127823

Metastasis to lymph nodes and distant organs is the main challenge in the treatment of papillary thyroid cancer. In the current investigation, we aimed to evaluate the synergistic effects of celecoxib (CX) and sodium valproate (VPA) against…

2014
·PMID:25276180

A simple and rapid stability indicating method based on capillary zone electrophoresis has been developed and validated for the analysis of buserelin (BUS). The best separations were achieved by using a bare fused silica capillary (75 μm i.…

2010
·PMID:24381601

Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Frequent injection of drug decreases patients' compliance. Th…